JUPITER, Fla., Mar 25, 2014 (BUSINESS WIRE) — BioRestorative Therapies, Inc. (”BRT” or the “Company”) (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement (”Agreement”) with Rohto Pharmaceutical Company, Ltd. (”Rohto”). Under the Agreement, BRT has been engaged to provide stem cell research and development services.
http://www.publicwire.com/2014/03/25/brtx-biorestorative-therapies-signs-research-and-development-agreement-with-rohto-pharmaceutical/
No comments:
Post a Comment